Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib

Saturday, March 30, 2024

InnoCare Pharma a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase b clinical study of the combination of InnoCares

IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma

Friday, March 29, 2024

IASO Bio a biopharmaceutical company engaged in discovering developing manufacturing and marketing innovative cell therapies and antibody products today announced that China National Medical Products

An ActRIIA Fusion Protein Got FDA Approved for PAH Treatment

Saturday, March 30, 2024

On March th the US FDA granted approval for Mercks WINREVAIR sotaterceptcsrk marking a significant milestone in pulmonary arterial hypertension PAH treatment PAH characterized by elevated blood pressure in the arteries connecting the heart and lungs...

Biocon is the First Generics Company to Obtain Approval for Diabetes Drug, Liraglutide, in the U.K.

Thursday, March 28, 2024

Biocon Limited an innovationled global biopharmaceuticals company announced today that it has received approval from the Medicines and Healthcare Products Regulatory Agency UK for its complex formulation

ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP

Thursday, March 28, 2024

ANI Pharmaceuticals Inc today announced the launch of Levofloxacin Oral Solution a generic version of the Reference Listed Drug Levaquin The current annual US market for Levofloxacin Oral Solution is approximately million according to latest estimat...

Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

Thursday, March 28, 2024

Oncopeptides AB a biotech company focused on difficulttotreat cancers and Vector Pharma FZCO today announced a collaboration to commercialize Oncopeptides flagship drug Pepaxti

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China’s NMPA

Thursday, March 28, 2024

Santhera Pharmaceuticals announces that the China National Medical Products Administration has accepted for priority review the new drug application for vamorolone

Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy

Wednesday, March 27, 2024

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and

TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients

Wednesday, March 27, 2024

TiumBio Co Ltd a clinicalstage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable diseases has announced the filing of a Clinical

Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology

Wednesday, March 27, 2024

Bridge Biotherapeutics a South Korean clinicalstage biotech company developing novel drugs for cancer